Univdatos Whatsapp
Aseptic Pharma Processing Market

Global Aseptic Pharma Processing Market is Expected to Foresee Significant Growth During the Forecast Period. North America to Witness the Highest Growth

Global aseptic pharma processing market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 8% during the forecast period (2021-2027). Aseptic Pharma Processing is the processing of various pharmaceutical products including drug components, drug product containers, and excipients in a manner that prevents any microbial contamination of the final sealed product.

For a detailed analysis of the aseptic pharma processing  browse through https://univdatos.com/report/aseptic-pharma-processing-market/

The growth of the aseptic pharma processing market across the world can be attributed to the increase in foreign direct investment (FDI) in the drugs & pharmaceutical sector. For instance, As of December 2020, the drugs and pharmaceuticals sector in India saw a foreign direct investment equity inflow worth nearly 1.3 billion U.S. dollars for the financial year 2021, up from USD 266 million in 2019. Owing to these investments, more and more biotechnology and pharmaceutical companies are investing in R&D to discover new and potential drugs which in turn is driving the demand for various aseptic processing facilities all over the globe. Thereby, boosting the growth of the aseptic pharma processing market.

Furthermore, the growing geriatric population coupled with a rise in eye-related disorders globally are also driving the demand for ophthalmic suspensions for its treatment. Owing to this, many pharmaceutical companies are focusing on launching new products which in turn is augmenting the demand for aseptic pharma processing facilities. For instance, in March 2021, Indoco launched  Brinzolamide Ophthalmic Suspension 1% in the U. S. It is the first generic version of AZOPT by Teva Pharmaceuticals and is used to treat ocular hypertension and open-angle glaucoma, which cause high pressure inside the eye.

For a detailed analysis of the market drivers of aseptic pharma processing  browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=19309

Based on components, the market is segmented into processing equipment and packaging equipment. The processing equipment segment grabbed an XX% share of the global aseptic pharma processing market and will witness a considerable CAGR of XX% during the forecast period (2021-2027F) owing to the growing demand for the prolonged shelf life and aseptic processing of the pharmaceuticals. However, the packaging equipment is also anticipated to grow in the upcoming years due to the surging demand for eco-friendly and hygienic packaging for pharmaceutical products.

Based on the technology, the global aseptic pharma processing market is segmented into drying, lyophilization, closed vial technology, blow fill seal technology, and others. The lyophilization segment occupied a substantial share and is expected to grow at a CAGR of XX% during the forecast period 2021-2027 on the account of its assurance to keep an aseptic environment for the pharmaceutical product. However, the blow-fill-seal technology segment is also likely to witness considerable growth during the forecast period as this technology is extensively used in liquid pharmaceutical applications and is gradually proliferating into biologics.

Request for Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=19309

Additionally, the report provides detailed report also provides insights into the global aseptic pharma processing market according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the well-established market players and increasing geriatric population.

Abbvie Inc., Lonza Group, Baxter International Inc., Robert Bosch GmbH, Alcami Corporation, Amcor Plc, Becton, Dickinson & Co, Samsung Biologics, Symbiosis Pharmaceutical Services, Recro Pharma, are some of the key players operating in the global aseptic pharma processing market. Several M&As along with partnerships have been undertaken by these players to develop new products.

Global Aseptic Pharma Processing Market Segmentation

Market Insight, by Component

  • Processing Equipment
  • Packaging Equipment

Market Insight, by Technology

  • Drying
  • Lyophilization
  • Closed Vial Technology
  • Blow Fill Seal Technology
  • Others

Market Insight, by Application

  • Ophthalmic Suspensions
  • Reconstituted Lyophilized Powders for Injection
  • Sterile Injectables
  • Aqueous-Based Aerosols for Inhalation
  • Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Australia
    • Japan
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Abbvie Inc.
  • Lonza Group
  • Baxter International Inc.
  • Robert Bosch GmbH
  • Alcami Corporation
  • Amcor Plc
  • Becton, Dickinson & Co
  • Samsung Biologics
  • Symbiosis Pharmaceutical Services
  • Recro Pharma

Leave A Comment

Select Language